The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Treatment strategies for women with polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women, and it is the main cause of infertility in women of reproductive age due to anovulation. PCOS also increases the risk of diseases such as cardiovascular disease and type 2 diabetes in women with this disorder. The mechanism of pathogenesis is not clear, as it may be related to heredity, the environment and internal embryonic factors; thus, the treatment strategies remain unclear. This review summarizes current treatments for PCOS worldwide. Lifestyle modification (LSM) is considered the first-line treatment, regardless of fertility status, without the addition of metformin. Oral contraceptive (OC) pills should be used as a first-line treatment for long-term management for patients with no reproductive requirements. For patients with fertility requirements, ovulation therapy is an effective treatment. For refractory ovulation disorders, patients can choose from among the latest treatments, including ovarian hippocampal signal path block theory, the theory of leptin, inositol treatment, bilateral ovarian drilling to stimulate ovulation and assisted reproductive technology. Because current treatments cannot cure PCOS, lifelong administration is still the mainstream method of management; however, the optimal treatment plan needs further research and exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Women with PCOS with insulin resistance or hyperinsulinaemia have increased secretion of the ovaries and adrenal glands [40,41].”
BackgroundNorman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589 · cited 2×
“[11], increased risk of cardiovascular disease and type 2 diabetes [12].”
BackgroundAbdominal adiposity and the polycystic ovary syndrome
Escobar-Morreale, H. F., & Millán, J. L. S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.003 · Cited by 386 · cited 2×
“[59] have summarized the mechanism and role of leptin over the past 20 years and have made it clear that leptin has an effect on the levels of gonadotropin through the central level in the brain, adjusting the hypothalamus-pituitary gonad (HPG) axis function and that leptin contributes to the maturation and ovulation…”
BackgroundMethodAssisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE
(2016) · Human Reproduction · doi:10.1093/humrep/dew151 · Cited by 377
Sitruk-Ware, R., & Nath, A. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.09.004 · Cited by 247 · cited 3×
“Some studies have found that ethinylestradiol has stronger effects on liver metabolism than natural estradiol, including the synthesis of SHBG, angiotensin, and some blood coagulation factors dependent on estrogen [22].”
BackgroundLifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Domecq, J. P., Prutsky, G., Mullan, R. J., Hazem, A., Sundaresh, V., Elamin, M. B., Phung, O. J., Wang, A., Hoeger, K., Pasquali, R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2385 · Cited by 184
Cassina, M., Donà, M., Di Gianantonio, E., Litta, P., & Clementi, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu022 · Cited by 143 · cited 1×
“food and drug administration’s drug safety classification, although a meta-analysis showed that the early use of metformin by PCOS patients did not increase the risk of birth defects [53], but it should still be used with caution.”
BackgroundLadson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.002 · Cited by 138 · cited 2×
“Lifestyle adjustment (LSM) should be considered a primary treatment regardless of fertility requirements, without the addition of metformin to treat [18].”
BackgroundMethod
Cited by
Xing, C., Zhang, J., Zhao, H., & He, B. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s344542 · Cited by 118
Ashkar, F., Rezaei, S., Salahshoornezhad, S., Vahid, F., Gholamalizadeh, M., Dahka, S. M., & Doaei, S. (2020) · BioMolecular Concepts · doi:10.1515/bmc-2020-0005 · Cited by 68
Preventive online and offline health management intervention in polycystic ovary syndrome
Liu, R., Li, M., Wang, P., Yu, M., Wang, Z., & Zhang, G.-Z. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i10.3060 · Cited by 7
Metadata
- Authors
- Jin, P., & Xie, Y.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2017-10-31
- Volume
- 34
- Issue
- 4
- Pages
- 272-277
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2765306718
- Cited by
- 175
- References
- 15
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment strategies for women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1080/09513590.2017.1395841
- The paper
- Jin, P., & Xie, Y. (2018). Treatment strategies for women with polycystic ovary syndrome. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2017.1395841
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.